Biocon rises 3% as co enters Brazilian generic formulation marketChief Executive Officer and Managing Director, Siddharth Mittal, Biocon Ltd, said the association with Libbs Farmaceutica will help his com...
Biocon partners with Libbs Farmaceutica to launch generic drugs in BrazilThis partnership, which marks the entry of Biocon’s generic formulations into Latin America, builds upon a successful association with Libb...
Mylan-Biocon's breast cancer biosimilar gets ANVISA nodBiosimilar trastuzumab, indicated for breast cancer treatment, has been co-developed by Biocon and Mylan.